Molecular basis and genetic modifiers of thalassemia

No Thumbnail Available

Date

2018

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier Health Science

Abstract

Thalassemia is a disorder of hemoglobin characterized by reduced or absent production of one of the globin chains in human red blood cells with relative excess of the other. Impaired synthesis of β-globin results in β-thalassemia, whereas defective synthesis of α-globin leads to α-thalassemia. Despite being a monogenic disorder, thalassemia exhibits remarkable clinical heterogeneity that is directly related to the intracellular imbalance between α- and β-like globin chains. Novel insights into the genetic modifiers have contributed to the understanding of the correlation between genotype and phenotype and are being explored as therapeutic pathways to cure this life-limiting disease.

Description

Indexed In MEDLINE

Keywords

Gene regulation

Citation

Hematology/oncology Clinics of North America.2018;32(2):177-191

Endorsement

Review

Supplemented By

Referenced By